Arbovirus Testing Market Size, Share, Trends, Growth Outlook |2025-2034

The Global Arbovirus Testing Market Size is estimated at $1.4 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 4.6% to reach $2.1 Billion by 2034.

The market growth is driven by increasing the impact of climate change on the distribution and behavior of disease vectors, such as mosquitoes and ticks, which are influencing the spread of arboviruses. As these vectors expand their geographical range, regions that were previously unaffected may now be at risk. This changing landscape underscores the importance of continuous monitoring and effective arbovirus testing to adapt to evolving epidemiological patterns. Leading Companies focusing on Multiplex Testing Platforms for Comprehensive Diagnosis, Advancements in Antigen Detection Techniques, and others to boost market shares in the industry.

Arbovirus Testing Market Overview

The arbovirus testing market, focused on diagnosing arthropod-borne viruses like dengue and Zika transmitted by mosquitoes and ticks, has witnessed growth propelled by increasing global incidence of arboviral infections. Key drivers include technological advancements in diagnostics, government support for health initiatives, and rising awareness of public health implications. Challenges include resource constraints in some regions and the complexity of arboviral diseases with nonspecific symptoms. Opportunities for market expansion lie in the adoption of point-of-care testing solutions and ongoing research for improved testing methods. The market's future trajectory is influenced by dynamic factors, such as advancements in artificial intelligence and machine learning, multiplex testing platforms, and innovations in antigen detection techniques.

Arbovirus Testing Market Competitive Landscape

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments across Abbott Laboratories, Agilent Technologies Inc, Bio-Rad, Copley Scientific, DiaSorin SpA, Distek, Euroimmun AG, Fluke Biomedical, NovaTec Immundiagnostica GmbH, Thermo Fisher Scientific

Arbovirus Testing Market Dynamics

Market Trends- The surge in arbovirus infections is propelling the demand for faster and more accurate diagnostic tools, leading to the adoption of cutting-edge arbovirus testing technologies.

The global rise in arbovirus infections has led to an increased demand for advanced diagnostic tools, that emphasize both speed and accuracy. This growing need is fueling the adoption of cutting-edge arbovirus testing technologies, which include molecular testing methods like Polymerase Chain Reaction (PCR) and serological assays. These state-of-the-art technologies not only improve diagnostic precision but also contribute to quicker turnaround times, facilitating timely and efficient patient management. To address the urgency in controlling diseases such as dengue, Zika, and chikungunya, healthcare systems and laboratories are investing in advanced testing solutions. Furthermore, the momentum is building for point-of-care testing (POCT), allowing rapid and decentralized testing, particularly beneficial in regions prone to arboviral outbreaks and areas with limited healthcare infrastructure. As the landscape of arbovirus infections evolves, the integration of innovative diagnostic tools remains crucial in overcoming challenges associated with these vector-borne diseases.

Market Driver- Rapidly evolving testing methods are fueling significant growth in the Arbovirus Testing Market.

The Arbovirus Testing Market is experiencing significant growth due to the rapid advancement of testing methods. Molecular diagnostics, including Polymerase Chain Reaction (PCR) and serological assays, are driving technological progress, substantially enhancing the precision and efficiency of arbovirus testing. These state-of-the-art testing techniques deliver quicker results and improved accuracy in diagnosing arboviral infections transmitted by vectors like mosquitoes and ticks. The increasing adoption of point-of-care testing (POCT) solutions is pivotal in expediting the diagnostic process and facilitating prompt clinical decisions and public health interventions. Ongoing research and development initiatives are continuously introducing innovative testing technologies, ensuring the market's dynamic evolution to meet the rising demands for timely and accurate arbovirus detection. This trend highlights the industry's commitment to maintaining a leading position in diagnostic capabilities, ultimately benefiting healthcare providers and the global population in the effective management of arboviral diseases.

Market Opportunity- The growing public understanding of arbovirus dangers and governments taking preemptive measures are driving the Arbovirus Testing Market's boom.

The upsurge in public awareness regarding the risks associated with arboviruses, combined with proactive government initiatives, plays a pivotal role in driving the expansion of the Arbovirus Testing Market. Increased understanding of the severe health consequences of arboviral infections like dengue, Zika, and chikungunya has motivated individuals to actively seek timely and precise diagnostic solutions. Governments worldwide are progressively acknowledging the public health threat posed by these vector-borne diseases, taking preemptive actions to curb outbreaks. These actions involve substantial investments in robust surveillance systems, strategic public health campaigns, and funding allocations for the advancement and deployment of cutting-edge arbovirus testing technologies. Collaborative endeavors among public health organizations, research institutions, and governments are fostering innovation in testing methodologies, contributing to a surge in the Arbovirus Testing Market as the global community strives to bolster preparedness and minimize the impact of arboviral outbreaks.

Arbovirus Testing Market Share Analysis: Molecular Diagnostics Segment is expected to register the fastest growth rate (CAGR) over the forecast period from 2025 to 2034.

The molecular diagnostics segment is anticipated to be the fastest-growing technology in the arbovirus testing market through 2034, driven by its high sensitivity, rapid turnaround times, and ability to detect low viral loads across multiple arboviruses, including Zika, Dengue, and Chikungunya. This technology enables early and accurate detection, which is critical for disease management and outbreak containment, especially in regions prone to vector-borne epidemics. The expansion of point-of-care molecular platforms and ongoing innovation in multiplex PCR and isothermal amplification techniques are further enhancing accessibility and efficiency. Additionally, global public health initiatives and funding for epidemic preparedness are accelerating the adoption of molecular diagnostics in both centralized labs and decentralized settings, reinforcing its position as the fastest-growing segment in the arbovirus testing landscape.

Arbovirus Testing Market Share Analysis- Point of Care held a significant market share in 2024

The Global Product Engineering Service Market is analyzed across various locations including Point of Care, Central Laboratories, and others. Of these, Point of Care held a significant market share in 2024. The Point-of-Care (POC) Arbovirus Testing Market is experiencing significant growth due to advances in diagnostic technologies and the escalating demand for rapid, decentralized testing. POC testing provides quick results, accessibility in remote areas, and immediate clinical decision-making for arboviral infections like dengue and Zika. Portable and user-friendly testing devices are driving expansion, particularly in regions susceptible to outbreaks. Positioned at the forefront of the global healthcare focus on early detection and management of arboviral diseases, the Point-of-Care Arbovirus Testing Market is poised for sustained growth and continued innovation.

Arbovirus Testing Market Segmentation

By Product

• Instruments
• Reagents
• Software Services

By Type

• ELISA-Based Tests
• RT-PCR Based Tests
• Others

By Technology

• Immunoassay
• Molecular Diagnostics
• Polymerase Chain Reaction (PCR)
• In Situ Hybridization
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Chips and Microarrays
• Sequencing & NGS
• Transcription Mediated Amplification
• Microbiology

By Application

• MRSA
• Streptococcus
• Clostridium Difficile
• VRE
• CRE
• Respiratory Virus
• Candida
• TB and Drug-resistant TB
• Gastro-intestinal Panel Testing
• Chlamydia
• Gonorrhea
• HPV
• HIV
• Hepatitis C
• Hepatitis B
• COVID-19
• Others

By Location

• Point of Care
• Central Laboratories
• Others

By Region 

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

Arbovirus Testing Companies Profiled in the Study

• Agilent Technologies Inc
• Thermo Fisher Scientific
• NovaTec Immundiagnostica GmbH
• Euroimmun AG
• Abbott Laboratories
• DiaSorin SpA
• Bio-Rad
• Fluke Biomedical
• Copley Scientific
• Distek

*List not exhaustive

Arbovirus Testing Market Outlook 2025

1 Market Overview

1.1 Introduction to the Arbovirus Testing Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2024 Arbovirus Testing Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Arbovirus Testing Market Companies with Area Served

4.2.2 Products Offerings Global Arbovirus Testing Market

 

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 post-COVID-19 Scenario- Low Growth Case

5.1.3 post-COVID-19 Scenario- Reference Growth Case

5.1.4 post-COVID-19 Scenario- Low Growth Case

 

6 Global Arbovirus Testing Market Trends

6.1 Global Arbovirus Testing Revenue (USD Million) and CAGR (%) by Type (2019-2032)

6.2 Global Arbovirus Testing Revenue (USD Million) and CAGR (%) by Applications (2019-2032)

6.3 Global Arbovirus Testing Revenue (USD Million) and CAGR (%) by regions (2019-2032)

 

7 Global Arbovirus Testing Market Revenue (USD Million) by Type, and Applications (2019-2024)

7.1 Global Arbovirus Testing Revenue (USD Million) by Type (2019-2024)

7.1.1 Global Arbovirus Testing Revenue (USD Million), Market Share (%) by Type (2019-2024)

7.2 Global Arbovirus Testing Revenue (USD Million) by Applications (2019-2024)

7.2.1 Global Arbovirus Testing Revenue (USD Million), Market Share (%) by Applications (2019-2024)

 

8 Global Arbovirus Testing Development Regional Status and Outlook

8.1 Global Arbovirus Testing Revenue (USD Million) By Regions (2019-2024)

8.2 North America Arbovirus Testing Revenue (USD Million) by Type, and Application (2019-2024)

8.2.1 North America Arbovirus Testing Revenue (USD Million) by Country (2019-2024)

8.2.2 North America Arbovirus Testing Revenue (USD Million) by Type (2019-2024)

8.2.3 North America Arbovirus Testing Revenue (USD Million) by Applications (2019-2024)

8.3 Europe Arbovirus Testing Revenue (USD Million), by Type, and Applications (USD Million) (2019-2024)

8.3.1 Europe Arbovirus Testing Revenue (USD Million), by Country (2019-2024)

8.3.2 Europe Arbovirus Testing Revenue (USD Million) by Type (2019-2024)

8.3.3 Europe Arbovirus Testing Revenue (USD Million) by Applications (2019-2024)

8.4 Asia Pacific Arbovirus Testing Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2019-2024)

8.4.1 Asia Pacific Arbovirus Testing Revenue (USD Million) by Country (2019-2024)

8.4.2 Asia Pacific Arbovirus Testing Revenue (USD Million) by Type (2019-2024)

8.4.3 Asia Pacific Arbovirus Testing Revenue (USD Million) by Applications (2019-2024)

8.5 South America Arbovirus Testing Revenue (USD Million), by Type, and Applications (2019-2024)

8.5.1 South America Arbovirus Testing Revenue (USD Million), by Country (2019-2024)

8.5.2 South America Arbovirus Testing Revenue (USD Million) by Type (2019-2024)

8.5.3 South America Arbovirus Testing Revenue (USD Million) by Applications (2019-2024)

8.6 Middle East and Africa Arbovirus Testing Revenue (USD Million), by Type, Technology, Application, Thickness (2019-2024)

8.6.1 Middle East and Africa Arbovirus Testing Revenue (USD Million) by Country (2019-2024)

8.6.2 Middle East and Africa Arbovirus Testing Revenue (USD Million) by Type (2019-2024)

8.6.3 Middle East and Africa Arbovirus Testing Revenue (USD Million) by Applications (2019-2024)

 

9 Company Profiles

 

10 Global Arbovirus Testing Market Revenue (USD Million), by Type, and Applications (2025-2034)

10.1 Global Arbovirus Testing Revenue (USD Million) and Market Share (%) by Type (2025-2034)

10.1.1 Global Arbovirus Testing Revenue (USD Million), and Market Share (%) by Type (2025-2034)

10.2 Global Arbovirus Testing Revenue (USD Million) and Market Share (%) by Applications (2025-2034)

10.2.1 Global Arbovirus Testing Revenue (USD Million), and Market Share (%) by Applications (2025-2034)

 

11 Global Arbovirus Testing Development Regional Status and Outlook Forecast

11.1 Global Arbovirus Testing Revenue (USD Million) By Regions (2025-2034)

11.2 North America Arbovirus Testing Revenue (USD Million) by Type, and Applications (2025-2034)

11.2.1 North America Arbovirus Testing Revenue (USD) Million by Country (2025-2034)

11.2.2 North America Arbovirus Testing Revenue (USD Million), by Type (2025-2034)

11.2.3 North America Arbovirus Testing Revenue (USD Million), Market Share (%) by Applications (2025-2034)

11.3 Europe Arbovirus Testing Revenue (USD Million), by Type, and Applications (2025-2034)

11.3.1 Europe Arbovirus Testing Revenue (USD Million), by Country (2025-2034)

11.3.2 Europe Arbovirus Testing Revenue (USD Million), by Type (2025-2034)

11.3.3 Europe Arbovirus Testing Revenue (USD Million), by Applications (2025-2034)

11.4 Asia Pacific Arbovirus Testing Revenue (USD Million) by Type, and Applications (2025-2034)

11.4.1 Asia Pacific Arbovirus Testing Revenue (USD Million), by Country (2025-2034)

11.4.2 Asia Pacific Arbovirus Testing Revenue (USD Million), by Type (2025-2034)

11.4.3 Asia Pacific Arbovirus Testing Revenue (USD Million), by Applications (2025-2034)

11.5 South America Arbovirus Testing Revenue (USD Million), by Type, and Applications (2025-2034)

11.5.1 South America Arbovirus Testing Revenue (USD Million), by Country (2025-2034)

11.5.2 South America Arbovirus Testing Revenue (USD Million), by Type (2025-2034)

11.5.3 South America Arbovirus Testing Revenue (USD Million), by Applications (2025-2034)

11.6 Middle East and Africa Arbovirus Testing Revenue (USD Million), by Type, and Applications (2025-2034)

11.6.1 Middle East and Africa Arbovirus Testing Revenue (USD Million), by region (2025-2034)

11.6.2 Middle East and Africa Arbovirus Testing Revenue (USD Million), by Type (2025-2034)

11.6.3 Middle East and Africa Arbovirus Testing Revenue (USD Million), by Applications (2025-2034)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Arbovirus Testing Market Companies with Areas Served

Table 3 Products Offerings Global Arbovirus Testing Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Arbovirus Testing Revenue (USD Million) And CAGR (%) By Type (2019-2032)

Table 8 Global Arbovirus Testing Revenue (USD Million) And CAGR (%) By Applications (2019-2032)

Table 9 Global Arbovirus Testing Revenue (USD Million) And CAGR (%) By Regions (2019-2032)

Table 10 Global Arbovirus Testing Revenue (USD Million) By Type (2019-2024)

Table 11 Global Arbovirus Testing Revenue Market Share (%) By Type (2019-2024)

Table 12 Global Arbovirus Testing Revenue (USD Million) By Applications (2019-2024)

Table 13 Global Arbovirus Testing Revenue Market Share (%) By Applications (2019-2024)

Table 14 Global Arbovirus Testing Market Revenue (USD Million) By Regions (2019-2024)

Table 15 Global Arbovirus Testing Market Share (%) By Regions (2019-2024)

Table 16 North America Arbovirus Testing Revenue (USD Million) By Country (2019-2024)

Table 17 North America Arbovirus Testing Revenue (USD Million) By Type (2019-2024)

Table 18 North America Arbovirus Testing Revenue (USD Million) By Applications (2019-2024)

Table 19 Europe Arbovirus Testing Revenue (USD Million) By Country (2019-2024)

Table 20 Europe Arbovirus Testing Revenue (USD Million) By Type (2019-2024)

Table 21 Europe Arbovirus Testing Revenue (USD Million) By Applications (2019-2024)

Table 22 Asia Pacific Arbovirus Testing Revenue (USD Million) By Country (2019-2024)

Table 23 Asia Pacific Arbovirus Testing Revenue (USD Million) By Type (2019-2024)

Table 24 Asia Pacific Arbovirus Testing Revenue (USD Million) By Applications (2019-2024)

Table 25 South America Arbovirus Testing Revenue (USD Million) By Country (2019-2024)

Table 26 South America Arbovirus Testing Revenue (USD Million) By Type (2019-2024)

Table 27 South America Arbovirus Testing Revenue (USD Million) By Applications (2019-2024)

Table 28 Middle East and Africa Arbovirus Testing Revenue (USD Million) By Region (2019-2024)

Table 29 Middle East and Africa Arbovirus Testing Revenue (USD Million) By Type (2019-2024)

Table 30 Middle East and Africa Arbovirus Testing Revenue (USD Million) By Applications (2019-2024)

Table 31 Financial Analysis

Table 32 Global Arbovirus Testing Revenue (USD Million) By Type (2025-2034)

Table 33 Global Arbovirus Testing Revenue Market Share (%) By Type (2025-2034)

Table 34 Global Arbovirus Testing Revenue (USD Million) By Applications (2025-2034)

Table 35 Global Arbovirus Testing Revenue Market Share (%) By Applications (2025-2034)

Table 36 Global Arbovirus Testing Market Revenue (USD Million), And Revenue (USD Million) By Regions (2025-2034)

Table 37 North America Arbovirus Testing Revenue (USD)By Country (2025-2034)

Table 38 North America Arbovirus Testing Revenue (USD Million) By Type (2025-2034)

Table 39 North America Arbovirus Testing Revenue (USD Million) By Applications (2025-2034)

Table 40 Europe Arbovirus Testing Revenue (USD Million) By Country (2025-2034)

Table 41 Europe Arbovirus Testing Revenue (USD Million) By Type (2025-2034)

Table 42 Europe Arbovirus Testing Revenue (USD Million) By Applications (2025-2034)

Table 43 Asia Pacific Arbovirus Testing Revenue (USD Million) By Country (2025-2034)

Table 44 Asia Pacific Arbovirus Testing Revenue (USD Million) By Type (2025-2034)

Table 45 Asia Pacific Arbovirus Testing Revenue (USD Million) By Applications (2025-2034)

Table 46 South America Arbovirus Testing Revenue (USD Million) By Country (2025-2034)

Table 47 South America Arbovirus Testing Revenue (USD Million) By Type (2025-2034)

Table 48 South America Arbovirus Testing Revenue (USD Million) By Applications (2025-2034)

Table 49 Middle East and Africa Arbovirus Testing Revenue (USD Million) By Region (2025-2034)

Table 50 Middle East and Africa Arbovirus Testing Revenue (USD Million) By Region (2025-2034)

Table 51 Middle East and Africa Arbovirus Testing Revenue (USD Million) By Type (2025-2034)

Table 52 Middle East and Africa Arbovirus Testing Revenue (USD Million) By Applications (2025-2034)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Arbovirus Testing Revenue (USD Million) By Type (2019-2024)

Figure 4 Global Arbovirus Testing Revenue Market Share (%) By Type (2022)

Figure 5 Global Arbovirus Testing Revenue (USD Million) By Applications (2019-2024)

Figure 6 Global Arbovirus Testing Revenue Market Share (%) By Applications (2022)

Figure 7 Global Arbovirus Testing Market Revenue (USD Million) By Regions (2019-2024)

Figure 8 Global Arbovirus Testing Market Share (%) By Regions (2022)

Figure 9 North America Arbovirus Testing Revenue (USD Million) By Country (2019-2024)

Figure 10 North America Arbovirus Testing Revenue (USD Million) By Type (2019-2024)

Figure 11 North America Arbovirus Testing Revenue (USD Million) By Applications (2019-2024)

Figure 12 Europe Arbovirus Testing Revenue (USD Million) By Country (2019-2024)

Figure 13 Europe Arbovirus Testing Revenue (USD Million) By Type (2019-2024)

Figure 14 Europe Arbovirus Testing Revenue (USD Million) By Applications (2019-2024)

Figure 15 Asia Pacific Arbovirus Testing Revenue (USD Million) By Country (2019-2024)

Figure 16 Asia Pacific Arbovirus Testing Revenue (USD Million) By Type (2019-2024)

Figure 17 Asia Pacific Arbovirus Testing Revenue (USD Million) By Applications (2019-2024)

Figure 18 South America Arbovirus Testing Revenue (USD Million) By Country (2019-2024)

Figure 19 South America Arbovirus Testing Revenue (USD Million) By Type (2019-2024)

Figure 20 South America Arbovirus Testing Revenue (USD Million) By Applications (2019-2024)

Figure 21 Middle East and Africa Arbovirus Testing Revenue (USD Million) By Region (2019-2024)

Figure 22 Middle East and Africa Arbovirus Testing Revenue (USD Million) By Type (2019-2024)

Figure 23 Middle East and Africa Arbovirus Testing Revenue (USD Million) By Applications (2019-2024)

Figure 24 Global Arbovirus Testing Revenue (USD Million) By Type (2025-2034)

Figure 25 Global Arbovirus Testing Revenue Market Share (%) By Type (2030)

Figure 26 Global Arbovirus Testing Revenue (USD Million) By Applications (2025-2034)

Figure 27 Global Arbovirus Testing Revenue Market Share (%) By Applications (2030)

Figure 28 Global Arbovirus Testing Market Revenue (USD Million) By Regions (2025-2034)

Figure 29 North America Arbovirus Testing Revenue (USD Million) By Country (2025-2034)

Figure 30 North America Arbovirus Testing Revenue (USD Million) By Type (2025-2034)

Figure 31 North America Arbovirus Testing Revenue (USD Million) By Applications (2025-2034)

Figure 32 Europe Arbovirus Testing Revenue (USD Million) By Country (2025-2034)

Figure 33 Europe Arbovirus Testing Revenue (USD Million) By Type (2025-2034)

Figure 34 Europe Arbovirus Testing Revenue (USD Million) By Applications (2025-2034)

Figure 35 Asia Pacific Arbovirus Testing Revenue (USD Million) By Country (2025-2034)

Figure 36 Asia Pacific Arbovirus Testing Revenue (USD Million) By Type (2025-2034)

Figure 37 Asia Pacific Arbovirus Testing Revenue (USD Million) By Applications (2025-2034)

Figure 38 South America Arbovirus Testing Revenue (USD Million) By Country (2025-2034)

Figure 39 South America Arbovirus Testing Revenue (USD Million) By Type (2025-2034)

Figure 40 South America Arbovirus Testing Revenue (USD Million) By Applications (2025-2034)

Figure 41 Middle East and Africa Arbovirus Testing Revenue (USD Million) By Region (2025-2034)

Figure 42 Middle East and Africa Arbovirus Testing Revenue (USD Million) By Region (2025-2034)

Figure 43 Middle East and Africa Arbovirus Testing Revenue (USD Million) By Type (2025-2034)

Figure 44 Middle East and Africa Arbovirus Testing Revenue (USD Million) By Applications (2025-2034)

Figure 45 Bottom-Up and Top-Down Approaches for This Report

Figure 46 Data Triangulation

Arbovirus Testing Market Segmentation

By Product

• Instruments
• Reagents
• Software Services

By Type

• ELISA-Based Tests
• RT-PCR Based Tests
• Others

By Technology

• Immunoassay
• Molecular Diagnostics
• Polymerase Chain Reaction (PCR)
• In Situ Hybridization
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Chips and Microarrays
• Sequencing & NGS
• Transcription Mediated Amplification
• Microbiology

By Application

• MRSA
• Streptococcus
• Clostridium Difficile
• VRE
• CRE
• Respiratory Virus
• Candida
• TB and Drug-resistant TB
• Gastro-intestinal Panel Testing
• Chlamydia
• Gonorrhea
• HPV
• HIV
• Hepatitis C
• Hepatitis B
• COVID-19
• Others

By Location

• Point of Care
• Central Laboratories
• Others

By Region 

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)